173 related articles for article (PubMed ID: 25343963)
21. Vitamin D and Physical Activity in Patients With Colorectal Cancer: Epidemiological Evidence and Therapeutic Implications.
Morales-Oyarvide V; Meyerhardt JA; Ng K
Cancer J; 2016; 22(3):223-31. PubMed ID: 27341603
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D to prevent acute lung injury following oesophagectomy (VINDALOO): study protocol for a randomised placebo controlled trial.
Parekh D; Dancer RC; Lax S; Cooper MS; Martineau AR; Fraser WD; Tucker O; Alderson D; Perkins GD; Gao-Smith F; Thickett DR
Trials; 2013 Apr; 14():100. PubMed ID: 23782429
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcomes of stage IIB-IV melanoma patients: nationwide data from Norway.
Winge-Main A; Robsahm TE; Nyakas M; Festervoll G; Torkilseng E; Thybo S; Pati S; Carroll R
Future Oncol; 2023 Jan; 19(3):205-215. PubMed ID: 36974621
[TBL] [Abstract][Full Text] [Related]
24. Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma.
Newton-Bishop JA; Beswick S; Randerson-Moor J; Chang YM; Affleck P; Elliott F; Chan M; Leake S; Karpavicius B; Haynes S; Kukalizch K; Whitaker L; Jackson S; Gerry E; Nolan C; Bertram C; Marsden J; Elder DE; Barrett JH; Bishop DT
J Clin Oncol; 2009 Nov; 27(32):5439-44. PubMed ID: 19770375
[TBL] [Abstract][Full Text] [Related]
25. Real-world clinical outcomes of patients with stage IIB or IIC cutaneous melanoma treated at US community oncology clinics.
Samlowski W; Silver MA; Hohlbauch A; Zhang S; Scherrer E; Fukunaga-Kalabis M; Krepler C; Jiang R
Future Oncol; 2022 Oct; 18(33):3755-3767. PubMed ID: 36346064
[TBL] [Abstract][Full Text] [Related]
26. Current State of Adjuvant Therapy for Melanoma: Less Is More, or More Is Better?
Lao CD; Khushalani NI; Angeles C; Petrella TM
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-7. PubMed ID: 35658502
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness analysis of PET/CT surveillance imaging to detect systemic recurrence in resected stage III melanoma: study protocol.
Dieng M; Khanna N; Nguyen MTH; Turner R; Lord SJ; Menzies AM; Allen J; Saw R; Nieweg OE; Thompson J; Morton RL
BMJ Open; 2020 Nov; 10(11):e037857. PubMed ID: 33154047
[TBL] [Abstract][Full Text] [Related]
28. Current knowledge on the active form of Vitamin D synthesized in the skin and its effects on malignant melanoma.
Bolerazska B; Rabajdova M; Spakova I; Marekova M
Neoplasma; 2017; 64(1):1-12. PubMed ID: 27880999
[TBL] [Abstract][Full Text] [Related]
29. Treatment with coumarin to prevent or delay recurrence of malignant melanoma.
Thornes RD; Daly L; Lynch G; Breslin B; Browne H; Browne HY; Corrigan T; Daly P; Edwards G; Gaffney E
J Cancer Res Clin Oncol; 1994; 120 Suppl():S32-4. PubMed ID: 8132701
[TBL] [Abstract][Full Text] [Related]
30. A randomised trial evaluating bevacizumab as adjuvant therapy following resection of AJCC stage IIB, IIC and III cutaneous melanoma: an update.
Biswas S; Wrigley J; East C; Hern A; Marshall A; Dunn J; Lorigan P; Middleton M; Corrie P
Ecancermedicalscience; 2008; 2():108. PubMed ID: 22275984
[TBL] [Abstract][Full Text] [Related]
31. Pilot early phase II study of decitabine and carboplatin in patients with advanced melanoma.
van der Westhuizen A; Knoblauch N; Graves MC; Levy R; Vilain RE; Bowden NA
Medicine (Baltimore); 2020 Jun; 99(25):e20705. PubMed ID: 32569203
[TBL] [Abstract][Full Text] [Related]
32. Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow up? Statistical analysis plan for the MEL-SELF randomised controlled trial.
Medcalf E; Taylor A; Turner R; Espinoza D; Bell KJL
Contemp Clin Trials; 2022 Jun; 117():106761. PubMed ID: 35439647
[TBL] [Abstract][Full Text] [Related]
33. Real-World Recurrence Rates and Economic Burden in Patients with Resected Early-Stage Melanoma.
Jang S; Poretta T; Bhagnani T; Harshaw Q; Burke M; Rao S
Dermatol Ther (Heidelb); 2020 Oct; 10(5):985-999. PubMed ID: 32548707
[TBL] [Abstract][Full Text] [Related]
34. Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment.
Garbe C; Keim U; Amaral T; Berking C; Eigentler TK; Flatz L; Gesierich A; Leiter U; Stadler R; Sunderkötter C; Tüting T; Utikal J; Wollina U; Zimmer L; Zouboulis CC; Ascierto PA; Eggermont AMM; Grob JJ; Hauschild A; Sekulovic LK; Long GV; Luke JJ; Michielin O; Peris K; Schadendorf D; Kirkwood JM; Lorigan PC;
J Clin Oncol; 2022 Nov; 40(32):3741-3749. PubMed ID: 35709414
[TBL] [Abstract][Full Text] [Related]
35. Recurrence Patterns for Regionally Metastatic Melanoma Treated in the Era of Adjuvant Therapy: A Systematic Review and Meta-Analysis.
Pérez-Morales J; Broman KK; Bettampadi D; Haver MK; Zager JS; Schabath MB
Ann Surg Oncol; 2023 Apr; 30(4):2364-2374. PubMed ID: 36479663
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant systemic treatment for high-risk resected non-cutaneous melanomas: What is the evidence?
Tapia Rico G; Yong CH; Herrera Gómez RG
Crit Rev Oncol Hematol; 2021 Nov; 167():103503. PubMed ID: 34656746
[TBL] [Abstract][Full Text] [Related]
37. Relevance of Vitamin D in Melanoma Development, Progression and Therapy.
Brożyna AA; Hoffman RM; Slominski AT
Anticancer Res; 2020 Jan; 40(1):473-489. PubMed ID: 31892603
[TBL] [Abstract][Full Text] [Related]
38. Long-term survival after surgical treatment followed by adjuvant systemic therapy for primary duodenal melanoma.
Surjan RCT; do Prado Silveira S; Dos Santos ES; de Meirelles LR
Clin J Gastroenterol; 2020 Aug; 13(4):532-537. PubMed ID: 32198707
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant treatment for patients with surgically resected advanced-stage melanoma.
Grossmann KF
Clin Adv Hematol Oncol; 2015 Oct; 13(10):633-5. PubMed ID: 27058564
[No Abstract] [Full Text] [Related]
40. Vitamin D Enhances Anticancer Properties of Cediranib, a VEGFR Inhibitor, by Modulation of VEGFR2 Expression in Melanoma Cells.
Piotrowska A; Beserra FP; Wierzbicka JM; Nowak JI; Żmijewski MA
Front Oncol; 2021; 11():763895. PubMed ID: 35004285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
